Subcutaneous implantable cardioverter-defibrillator in prevention of sudden cardiac death in Poland — opinion paper endorsed by the Polish Cardiac Society Working Group on Heart Rhythm
Paweł Ptaszyński(Medical University of Lodz), Maciej Sterliński(Institute of Cardiology), Andrzej Przybylski(University of Rzeszów), Marcin Grabowski, Maciej Kempa(Gdańsk Medical University), Przemysław Mitkowski(Poznan University of Medical Sciences), Oskar Kowalski(Silesian Center for Heart Disease)
Cited by 7
Related Papers
Metoprolol succinate vs. ivabradine in the treatment of inappropriate sinus tachycardia in patients unresponsive to previous pharmacological therapy
|EP Europace|2012|107
Quantitative Assessment of Microvolt T‐Wave Alternans in Patients with Congestive Heart Failure
|Journal of Cardiovascular Electrophysiology|2005|84
Importance of complete revascularization in patients with acute myocardial infarction treated with percutaneous coronary intervention
|American Heart Journal|2007|80
Mid-term outcomes of triple-site vs. conventional cardiac resynchronization therapy: A preliminary study
|International Journal of Cardiology|2008|72